Maggie Toms

Maggie’s experience includes advising:

• An ad hoc group of lenders holding US$2.1 billion in convertible notes of semiconductor developer Wolfspeed on the company’s proposed prepackaged chapter 11 reorganization; the transaction involved approximately US$6.7 billion of debt and a restructuring support agreement with Wolfspeed’s key stakeholders*
• Altice France, a leading telecommunications provider, in its chapter 15 proceedings to seek recognition in the United States of its historic French restructuring involving more than €20 billion of debt*
• 8th Avenue Food & Provisions, a leading provider of private label food products, on acquiring Post Holdings, in a transaction that fully satisfied approximately US$815 million of 8th Avenue’s funded debt obligations*
• Hooters of America, LLC, an iconic casual dining and sports entertainment chain, and its affiliated debtors in their chapter 11 cases involving the restructuring of approximately US$380 million of funded debt. Hooters’ chapter 11 cases are the first whole-business securitization filings of their kind and are supported by US$40 million of debtor-in-possession financing and a Restructuring Support Agreement with near unanimous support from its key stakeholders*
• Brown University Health, a leading academic healthcare system based in Providence, Rhode Island, in its purchase of Saint Anne’s Hospital in Fall River and Morton Hospital in Taunton, Massachusetts, for US$175 million in the Steward Health Care System bankruptcy*
• Exactech, Inc., a leading manufacturer and developer of orthopedic implant devices and surgical instruments, and its affiliated debtors in their chapter 11 cases involving the restructuring of more than US$350 million of prepetition debt, as well as additional prepetition liabilities, securing approximately US$160 million in debtor-in-possession credit financing, and addressing billions in alleged tort liabilities*
• Amylyx Pharmaceuticals, a global pharmaceutical company focused on developing treatments for neurodegenerative diseases, in its successful bid of more than US$35.1 million to purchase the avexitide assets of Eiger BioPharmaceuticals, Inc. in the sale of Eiger’s assets pursuant to Section 363 of the bankruptcy code*
• Shoes For Crews, a leading producer of non-slip shoes, in a sale to a group of its secured lenders through voluntary chapter 11 proceedings and in securing approximately US$30 million in DIP financing from the acquiring secured lenders*

*Matter handled prior to joining Latham